GLP-1 Agonists Like Semaglutide Show Promise in Reducing Alcohol Use Disorder, Study Finds Feb 20, 2025 2 min read Updated: Nov 6, 2025 Recent research suggests that semaglutide, a medication primarily used for type 2 diabetes and weight management, may also help reduce alcohol consumption
Our clinicians combine orthopedic and movement expertise with individualized care to help you stay strong, active, and independentso you can feel your best at every stage of your journey
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox
Hormone therapy is a tool
TRIUMPH-1 trajectory (80 weeks + extension): Week 80: 28.3% average weight loss (2,339 patients) 104-week extension (BMI 35 subgroup): 30.3% average weight loss Weight loss does not plateau at 80 weeks it continues in longer treatment The TRIUMPH-1 104-week extension is the most important long-term efficacy signal we have